Literature DB >> 28431203

Donor safety in living donor liver transplantation: The Korean organ transplantation registry study.

Jae Geun Lee1, Kwang-Woong Lee2, Choon Hyuck David Kwon3, Chong Woo Chu4, Bong-Wan Kim5, Dong Lak Choi6, Young Kyoung You7, Dong-Sik Kim8, Yang Won Nah9, Koo Jeong Kang10, In Soek Choi11, Hee Chul Yu12, Geun Hong13, Ho-Seong Han2, Shin Hwang14, Myoung Soo Kim1.   

Abstract

Major concerns about donor safety cause controversy and limit the use of living donor liver transplantation to overcome organ shortages. The Korean Organ Transplantation Registry established a nationwide organ transplantation registration system in 2014. We reviewed the prospectively collected data of all 832 living liver donors who underwent procedures between April 2014 and December 2015. We allocated the donors to a left lobe group (n = 59) and a right lobe group (n = 773) and analyzed the relations between graft types and remaining liver volumes and complications (graded using the Clavien 5-tier grading system). The median follow-up was 19 months (range, 10-31 months). During the study period, 553 men and 279 women donated livers, and there were no deaths after living liver donation. The overall, biliary, and major complication (grade ≥ III) rates were 9.3%, 1.7%, and 1.9%, respectively. The graft types and remaining liver volume were associated with significantly different overall, biliary, and major complication rates. Of the 16 patients with major complications, 9 (56.3%) involved biliary complications (2 biliary strictures [12.5%] and 7 bile leakages [43.8%]). Among the 832 donors, the mean aspartate transaminase, alanine aminotransferase, and total bilirubin levels were 23.9 ± 8.1 IU/L, 20.9 ± 11.3 IU/L, and 0.8 ± 0.4 mg/dL, respectively, 6 months after liver donation. In conclusion, biliary complications were the most common types of major morbidity in living liver donors. Donor hepatectomy can be performed successfully with minimal and easily controlled complications. Our study shows that prospective, nationwide cohort data provide an important means of investigating the safety in living liver donation. Liver Transplantation 23 999-1006 2017 AASLD.
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28431203     DOI: 10.1002/lt.24778

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  16 in total

1.  Endoscopic treatment of biliary complications in donors after living donor liver transplantation in a high volume transplant center.

Authors:  Mehmet Ali Erdoğan; Yasir Furkan Çağın; Yahya Atayan; Yılmaz Bilgiç; Oğuzhan Yıldırım; Ali Riza Çalışkan; Murat Aladağ; Melih Karıncaoğlu; Sezai Yılmaz; Muhsin Murat Harputluoğlu
Journal:  Turk J Gastroenterol       Date:  2020-09       Impact factor: 1.852

2.  Liver Living Donation for Cancer Patients: Benefits, Risks, Justification.

Authors:  Silvio Nadalin; Lara Genedy; Alfred Königsrainer
Journal:  Recent Results Cancer Res       Date:  2021

Review 3.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Korean J Radiol       Date:  2019-07       Impact factor: 3.500

4.  2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2019-05-15       Impact factor: 4.519

5.  Complications and outcomes of 890 living liver donor hepatectomies at a single center: risks of saving loved one's life.

Authors:  Yücel Yankol; Nesimi Mecit; Turan Kanmaz; Münci Kalayoğlu; Koray Acarlı
Journal:  Turk J Surg       Date:  2020-06-08

6.  New-onset diabetes after adult liver transplantation in the Korean Organ Transplantation Registry (KOTRY) study.

Authors:  Jong Man Kim; Shin Hwang; Kwang-Woong Lee; Jae-Geun Lee; Je Ho Ryu; Bong-Wan Kim; Dong Lak Choi; Young Kyoung You; Dong-Sik Kim; Yang Won Nah; Koo Jeong Kang; Jai Young Cho; Geun Hong; In Seok Choi; Hee Chul Yu; Dongho Choi; Myoung Soo Kim
Journal:  Hepatobiliary Surg Nutr       Date:  2020-08       Impact factor: 7.293

7.  Use of minor donors for living donor liver transplantation and associated ethical issues.

Authors:  Shin Hwang; Gi-Won Song; Dong-Hwan Jung; Tae-Yong Ha; Gil-Chun Park; Chul-Soo Ahn; Deok-Bog Moon; Sung-Gyu Lee
Journal:  Korean J Transplant       Date:  2021-09-30

8.  Pure laparoscopic right hepatectomy of living donor is feasible and safe: a preliminary comparative study in China.

Authors:  Jiu-Lin Song; Jian Yang; Hong Wu; Lu-Nan Yan; Tian-Fu Wen; Yong-Gang Wei; Jia-Yin Yang
Journal:  Surg Endosc       Date:  2018-09-24       Impact factor: 4.584

9.  Pure laparoscopic donor right hepatectomy in a living donor with type 3a biliary variation: A case report.

Authors:  Young Seok Han; Heontak Ha; Hyung Jun Kwon; Jae Min Chun
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

Review 10.  Should living donor liver transplantation be an option when deceased donation is not?

Authors:  Sarah R Lieber; Thomas D Schiano; Rosamond Rhodes
Journal:  J Hepatol       Date:  2017-11-01       Impact factor: 30.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.